WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011146808) TOPICAL FORMULATION FOR A JAK INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/146808    International Application No.:    PCT/US2011/037291
Publication Date: 24.11.2011 International Filing Date: 20.05.2011
IPC:
A61K 9/107 (2006.01), A61K 31/519 (2006.01), A61K 47/10 (2006.01), A61K 9/00 (2006.01), A61K 47/06 (2006.01)
Applicants: INCYTE CORPORATION [US/US]; Experimental Station - Building 336 Route 141 & Henry Clay Road Wilmington, Delaware 19880 (US) (For All Designated States Except US).
PARIKH, Bhavnish [US/US]; (US) (For US Only).
SHAH, Bhavesh [US/US]; (US) (For US Only).
YELESWARAM, Krishnaswamy [US/US]; (US) (For US Only)
Inventors: PARIKH, Bhavnish; (US).
SHAH, Bhavesh; (US).
YELESWARAM, Krishnaswamy; (US)
Agent: GODDARD, Christine, A.; Fish & Richardson P.C. P.O. Box 1022 Minneapolis, Minnesota 55440-1022 (US)
Priority Data:
61/347,132 21.05.2010 US
Title (EN) TOPICAL FORMULATION FOR A JAK INHIBITOR
(FR) FORMULATION TOPIQUE POUR INHIBITEUR DE JAK
Abstract: front page image
(EN)This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
(FR)Cette invention concerne des formulations pharmaceutiques pour une application topique sur la peau qui comporte du (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile ou un sel de qualité pharmaceutique de celui-ci, ainsi que leur utilisation dans le traitement de troubles cutanés.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)